Scientists have discovered an antibiotic capable of fighting infections that kill hundreds of thousands of people each year, a breakthrough that could lead to the field’s first major new drug in more than quarter of a century.
The experimental drug, which was isolated from a sample of New England dirt, is called teixobactin.
It has not yet been tested in people, though it cured all mice infected with antibiotic-resistant staphylococci bacteria that usually kills 90 percent of the animals, according to a study published yesterday in the journal Nature.
Bacteria appear to have a particularly difficult time developing resistance to the drug, potentially overcoming a major problem with existing antibiotics, the study said.
“It should be used, if it gets successfully developed, as broadly as possible, because it is exceptionally well protected from resistance development,” said Kim Lewis, one of the study’s authors and a professor at Northeastern University in Boston.
Lewis estimated that it might take more than 30 years for bacteria to become resistant to teixobactin.
Lewis is also a cofounder of NovoBiotic Pharmaceuticals, which is developing the drug.
Teixobactin strikes multiple targets, including cell walls, said Tanja Schneider, a lead author of the study and professor at the University of Bonn in Germany.
Since the lipid structures it attacks do not adapt as quickly as frequently mutating proteins, it might take bacteria longer than usual to develop a survival tactic.
“Not only one target is attacked by teixobactin, but multiple targets, and they are all lethal,” Schneider said in a conference call with reporters.
For bacteria, it will be “very hard to modify this target, especially this part of the molecule that’s bound by teixobactin,” she said.
The last major new antibiotic, daptomycin, was discovered in the 1980s by Eli Lilly & Co. After being abandoned in early testing, the drug was licensed by Cubist Pharmaceuticals in 1997 and approved for sale in 2003. Merck & Co last year agreed to buy Cubist for US$8.4 billion.
Antibiotic-resistant bacteria kill at least 700,000 people a year, according to a UK government review.
Unchecked, those infections could lead to 10 million more deaths a year by 2050, the UK report found.
Many antibiotics are found in natural settings, sending drug researchers to rainforests, caves or, in the case of Cubist’s drug, Mount Ararat in Turkey, to hunt down potential treatments.
However, the producer of teixobactin was found in a grassy field in Maine.
The scientists used a new technique that cultivates bacteria in the lab using environments that mimic natural habitats.
“Some of the antibiotics are from exotic places, but the reason for that — there’s no scientific basis,” Lewis said in a telephone interview yesterday. “Common soils ... give you a very nice variety of all types of creatures. And a lot of isolates in the collection come from the backyard of Losee Ling, from NovoBiotic, and she lives in Lexington, Massachusetts.”
Ling is the company’s head of research and development.
The team has looked at 10,000 bacteria strains so far and, along with teixobactin, uncovered more than 20 new antibiotics, Lewis said during the press conference.
“This is a promising source in general for antibiotics and has a good chance of reviving the field,” the professor said.
The drug worked best against what are known as gram-positive bacteria, which have weaker cell walls and include streptococcus and methicillin-resistant Staphylococcus aureus. Gram-negative bacteria have stronger cell walls.
Teixobactin was also able to successfully attack drug-resistant strains of tuberculosis, which is neither clearly gram-positive nor gram-negative. The researchers are working on adaptations to make teixobactin effective against gram-negative cells as well.
It might take five to six years and hundreds of millions of dollars to bring the antibiotic to market, Lewis said.
“We’ve been seeing very high numbers for introducing the drug, between US$1 to US$2 billion, but part of that calculation takes into account the cost of failure,” Lewis said in the press briefing. “In this case, we have not been spending a lot of money so far and I think it will be in the low hundreds of millions to develop.”
An endangered baby pygmy hippopotamus that shot to social media stardom in Thailand has become a lucrative source of income for her home zoo, quadrupling its ticket sales, the institution said Thursday. Moo Deng, whose name in Thai means “bouncy pork,” has drawn tens of thousands of visitors to Khao Kheow Open Zoo this month. The two-month-old pygmy hippo went viral on TikTok and Instagram for her cheeky antics, inspiring merchandise, memes and even craft tutorials on how to make crocheted or cake-based Moo Dengs at home. A zoo spokesperson said that ticket sales from the start of September to Wednesday reached almost
‘BARBAROUS ACTS’: The captain of the fishing vessel said that people in checkered clothes beat them with iron bars and that he fell unconscious for about an hour Ten Vietnamese fishers were violently robbed in the South China Sea, state media reported yesterday, with an official saying the attackers came from Chinese-flagged vessels. The men were reportedly beaten with iron bars and robbed of thousands of dollars of fish and equipment on Sunday off the Paracel Islands (Xisha Islands, 西沙群島), which Taiwan claims, as do Vietnam, China, Brunei, Malaysia and the Philippines. Vietnamese media did not identify the nationalities of the attackers, but Phung Ba Vuong, an official in central Quang Ngai province, told reporters: “They were Chinese, [the boats had] Chinese flags.” Four of the 10-man Vietnamese crew were rushed
Scientists yesterday announced a milestone in neurobiological research with the mapping of the entire brain of an adult fruit fly, a feat that might provide insight into the brains of other organisms and even people. The research detailed more than 50 million connections between more than 139,000 neurons — brain nerve cells — in the insect, a species whose scientific name is Drosophila melanogaster and is often used in neurobiological studies. The research sought to decipher how brains are wired and the signals underlying healthy brain functions. It could also pave the way for mapping the brains of other species. “You might
INSTABILITY: If Hezbollah do not respond to Israel’s killing of their leader then it must be assumed that they simply can not, an Middle Eastern analyst said Israel’s killing of Hezbollah leader Hassan Nasrallah leaves the group under huge pressure to deliver a resounding response to silence suspicions that the once seemingly invincible movement is a spent force, analysts said. Widely seen as the most powerful man in Lebanon before his death on Friday, Nasrallah was the face of Hezbollah and Israel’s arch-nemesis for more than 30 years. His group had gained an aura of invincibility for its part in forcing Israel to withdraw troops from southern Lebanon in 2000, waging a devastating 33-day-long war in 2006 against Israel and opening a “support front” in solidarity with Gaza since
RSS